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Miroljub Đorđević 
 
 
Harmful air particles emissions (heavy industry, thermal and nuclear power plants, 
vehicles that burn fissile fuel, professional exposure in factories and mines, consumption 
of cigarettes), greatly disturb the function of the respiratory system. Obesity is 
associated with chronic low-grade inflammation and increased numbers of activated 
macrophages in adipose tissue. Adipose tissue provides an abundance of inflammatory 
mediators, suggesting a possible link between obesity and immunological developments 
in COPD.  
The aim of the paper was to determine whether obesity has a significant effect on 
spirometric parameters in patients with COPD, and to determine whether weight loss 
caused by reduction of adipose tissue has a positive effect on improvement of 
spirometric parameters in patients with COPD. 
The study included 190 examinees aged 35 to 65 years, of both sexes, divided into 
four groups: the first group recruited 40 examinees with different degrees of obesity and 
without verified COPD, 20 persons (group 1a) with obesity from I (BMI 30-35) to III 
(BMI>40) and 20 subjects (group 1b) with pre-obesity (BMI 25-30); the second group 
included 50 examinees who had normal nutritional status and COPD with different 
duration; the third group consisted of 50 examinees, who had I degree obesity (BMI 30-
35) and COPD; the fourth group consisted of 50 examinees, who had II degree obesity 
(BMI of 35-40) and COPD with different duration. 
The research lasted three years, covering the period from 2007 to 2010. The 
subjects were  being examineed for 180 days, and all the changes related to spirometry 
parameters and  body mass index (BMI) were followed up. 
 Comparing the average measures and standard deviations in FEV1/ FVC between 
groups 4 (66,71±4,53), 2 (69,1±5,98) and 3 (70,69±5,81), there were no significant 
statistical differences. The values of spirometric parameters between two groups of 
patients with COPD were compared. The first group of patients involved subjects who in 
the period of 180 days had weight loss greater than 10% and second (2) group in which 
subjects had no significant weight loss. It was found that respondents from the first 
group had a statistically significant increase in the observed values of all spirometric 
parameters compared to another group. FVC: 4.33(1) 0.99(2); p<0, 01. FEV1: 7.38(1) 
2.67(2); p<0.01. FEV1/FVC: 4,27(1) 2,14(2); p<0,05. 
Obesity has no significant effect on spirometric parameters in patients with COPD. 
Losing weight in favor of adipose tissue reducing has a significant effect on improving 
the spirometric parameters in patients with COPD. Acta Medica Medianae 2011; 50(4): 
11-16. 
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Introduction 
 
  Harmful air particles emissions (heavy 
industry, thermal and nuclear power plants, vehicles 
that burn fissile fuel, professional exposure in 
factories and mines, consumption of cigarettes), 
greatly disturb the function of the respiratory 
system. It simply gives any individual the right to 
ask whether there is a relationship between 
obesity and quality of breathing. We know that in 
some patients who have body mass index-BMI 
over 40, almost half of their body weight belongs 
to the adipose tissue (1). Two principal mechanical 
effects of obesity on respiratory lung function 
have been identified: an adipose tissue and 
muscle weakness. Analyzing the fat thickness 
(expressed in length), the visualization and 
measurement of which were enabled by applying 
this method, we found out that higher values of 
thickness are correlated with a higher degree of 
reduction in amplitude of the oscillation frequency 
and acceleration during the respiratory cycle in 
identical conditions. It was observed that especially Influence of obesity on spirometric parameters in patients...                                                                              Miroljub Đorđević 
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higher values of  abdominal fat have a significant 
effect on the above relationship (2) .  
  The weakness of respiratory muscles in obese 
individuals is attributed to muscle inefficiency. It is 
the result of reduced ability of the chest wall 
muscles (during the process of muscle contrac-
tions), which are surrounded by a layer of 
adipose tissue, reduced diaphragm movements, 
the primary muscle involved in the breathing 
action. On the other hand, the necessary 
circulation which delivers oxygen and nutrients 
for normal muscle functioning is compromised to 
some extent by different redistribution in obese 
people, causing all the muscles in general to 
suffer. This is supported by the fact that 
breathing exercises are used to enhance the lung 
capacity which is often weakened (of reduced 
intensity) in obese patients compared to 
examinees with normal body weight (3).  
  Obesity is associated with chronic low-
grade inflammation and increased number of active 
macrophages in the adipose tissue. Adipose tissue 
provides an abundance of inflammatory mediators, 
suggesting a possible link between obesity and 
immunological developments in COPD. This hypothesis 
is explained by histological preparations of adipose 
tissue on more than 10,000 samples, where the 
immune cytological analysis evidenced high 
number of macrophages in the connective tissue 
between the adipocytes. The presence of increased 
concentrations of C-reactive protein, tumor necrosis 
factor alpha (TNF-α) and interleukin-6 in the serum 
of the obese population has been undoubtedly 
proved (4) . 
 TNF-α is a proinflammatory cytokine which 
is mainly secreted by macrophages. It plays a 
role in the regulation of a wide range of biological 
processes, including cell proliferation, differentiation 
and apoptosis, which have physiological basis, 
particularly in modulation of mucous tissues in 
the respiratory tract, which is the main patho-
logical feature of COPD. 
  Reduction diets (reduced food intake) are 
definitely the optimal health strategies for the 
obese patients with chronic respiratory disease. 
Several studies have shown that therapeutic 
approaches, principles and maintaining of weight 
loss included food reduction, increase in physical 
activity and medical care (absorption of fats from 
digestive tract), whereby, in short time, a 
moderate degree of reduction in weight or fat 
tissue has been achieved. However, long-term 
investigation studies’ results have shown the 
opposite, because the majority of patients have 
succeeded to regain some or most of their weight 
(5). 
  There are no specific recommendations 
about weight loss, or appropriate strategies on 
regulation of body weight in patients with chronic 
respiratory diseases. This poses a problem, because 
patients with chronic respiratory diseases are often 
inactive, and therefore are often not able to comply 
with the recommendations related to the level of 
physical activity.  
  Aim 
 
•  To determine whether obesity has a 
significant effect on spirometric parameters in 
patients with COPD. 
•  To determine whether weight loss caused 
by reduction of adipose tissue has a positive 
effect on improvement of spirometric parameters 
in patients with COPD.  
 
  Patients and methods 
 
  The study included 190 examinees aged 
from 35 to 65 years old, of both sexes, divided 
into four groups. 
1.  The first group (1a) consisted of 40 
examinees with different degrees of obesity and 
without verified COPD, 20 individuals (group 1a) 
with obesity from I (BMI 30-35) to III (BMI> 40) 
and 20 individuals (group 1b) with pre-obesity 
(BMI 25-30).  
2.  The second group consisted of 50 examinees 
of different age structure, both sexes, who have 
normal nutritional status and COPD with different 
duration.  
3.  The third group consisted of 50 examinees 
of different age structure, both sexes, who had 
obesity degree (BMI 30-35) and COPD with 
different duration and degree severity. 
4.  The fourth group consisted of 50 examinees 
of different age structure, both sexes, who had II 
degree obesity (BMI of 35-40) and COPD of 
different duration and severity degree. 
  The research period lasted three years, 
from 2007 to 2010. Patients who fulfilled basic 
conditions for participation in the study underwent 
the clinical examination which included the 
important measurements of body weight, body 
height and calculation of BMI using the formula 
BMI=TT/TV2, as well as the waist measurements, 
on the basis of which the examinees were 
selected in groups according to degree obesity 
and obesity classification (WHO, 1997). The 
subjects were followed up for 180 days and spent 
15 days both at the beginning and end of the 
study in the home institution Special Hospital 
"Sokobanja" in Sokobanja, where besides diagnostic 
procedures (such as spirometry that is as a ratio 
between two parameters’ FEV1/FVC named as 
FVC - forced vital capacity and FEV1 - forced 
expiratory volume per 1 second), passed through 
the educational program and treatment of 
respiratory rehabilitation (that included the diet 
with limited food calorie intake in the range from 
1200 to 1800 kcal, physical activity twice a day 
with mat exercises, breathing exercises, extended 
breathing exercises, aqua fitness program and 
walking  tracks). 
  Survey results were analyzed using a 
software program for statistical analysis of data 
(SPSS). We used standard statistical parameters: 
arithmetic mean (Xsr.), standard deviation (SD), 
Fisher and Hi2-test, Student's t-test, linear corre-
lation, multivariate linear regression, whereby 
the results are presented in tables and graphs. Acta Medica Medianae 2011, Vol.50(4)                                                Influence of obesity on spirometric parameters in patients... 
 
             
Graph 1. Mean values and standard deviations of FEV1/FVC in the examined groups at the beginning (F=619,259; 
p<0,001) and end of 180 days (F=685,548; p<0,001) (ANOVA test, t-test for repeated measures)  
 
Table 1. Lung capacity in patients with reduced body weight by more than 10% and in those without body weight 
reduction - in patients with COPD (Mann-Whitney U test). 
 
 
Table 2. Parameters of body mass indexes of patients presented by groups (ANOVA comparison test)  A (1a vs 1b), 
B (1a vs 2), C (1a vs 3), D (1a vs 4), E (1b vs 2), F (2 vs 3), G (2 vs 4), H (1b vs 3), I (3 vs 4) 
 
  Group 1a  Group 1b  Group 2  Group 3  Group 4 
  X SD  X  SD X SD X SD  X  SD 
Height
A,C,D,E  1,64 0,05 1,78  0,03 1,68 0,06 1,75 0,1  1,77  0,06 
Weight
A,D,E,H,F,G,I  87,1 13,9 103,6 17  79,6 16,5 90,5 12,3 110,5 10,9 
Waist circumference
A,D,E,H,F,G,I  94,5 12,6 109,1 20,9 88,1 13,1 96,2 9,53 116,7 10,9 
BMI
B.E.G.I  32  4,88 32,66 5,54 28,1 5,7  29,9 5,84 35,1  2,82 
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Results 
 
Graph 1 presents mean values and standard 
deviations of FEV1/FVC in the examined groups at 
the beginning (F=619,259; p<0,001) and end of 
180 days (F=685,548; p<0,001) (ANOVA test, t-
test for repeated measures). Comparing the values 
at the beginning FEV1/ FVC and after a period of 
180 days, statistically significant differences in the 
values of the analyzed groups were observed. 
The lowest values at the beginning of testing 
were reported in group 4 (66,71±4, 53), which 
were significantly lower compared to the groups 1a 
(96, 87±3,45) and 1b (98, 10±3,77) but without 
significant difference compared to the values in 
group 2 (69,1±5,98). Statistically significant increase 
in the value at the end of the test occurred first in 
the group 2 (72,6±6,12) t=3,969; p<0,01, then in 
the group 3 (70,69±5,81) t=2,403; p=0,020 and in 
the group 4 (68,43±5,25) t=2,175; p=0,034, which 
  Reduction of BW>10%  Insignificant  reduction of BW     
  Mean (Me)  IR  Mean  (Me)  IR  Z  P 
∆FVC 4,33(5)  6,50  0,99(2)  8  -2,661  0,008 
∆FEV1 7,38(12)  15,50  2,67(49  8,5  -2,826  0,005 
∆FEV1/FVC 4,27(6,81)  13,95  2,14(2,15)  5,22  -2,288  0,022 Influence of obesity on spirometric parameters in patients...                                                                              Miroljub Đorđević 
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is marked by asterisks in the graph for p<0,05 (*) i 
p<0,01 (**), while for groups 1a (95,84±3,16) and 
1b (98,22±3,55), this phenomenon has not been 
confirmed. This clearly shows that there are no 
significant differences in the spirometric values of 
the parameter FEV1/FVC that reflects the lung 
function between patients from groups 2, 3 and 4 
and therefore we can conclude that obesity affects 
the decrease in spirometric parameters in patients 
with COPD. 
Table 1 shows lung capacity in patients with 
reduced body weight by more than 10% and in 
those without body weight reduction - in patients 
with COPD (Mann-Whitney U test). 
Table 1 shows the values of lung capacity 
and its decrease in patients before and after the 
treatment and rehabilitation (group of patients 
with COPD). The patients were divided in two 
groups. The first group involved the subjects 
whose body weight was reduced by more than 
10%, and the other group included the examinees 
whose body weight did not significantly change.   
As the data are very heterogeneous, for easier 
observation of changes of measured capacity, the 
change is shown by an average value, and median 
in parentheses, the interquartile difference as a 
measure of variability.  
We could perceive the average increase in 
FVC after the treatment and rehabilitation of 4.33 
in the group in which there was the reduction of 
TM and only 0.99 in those cases where there was 
no change in TM. Statistically significant difference 
was observed (Z=- 2.661, p=0.008).  
A change in FEV1 occurred more frequently 
in patients with a decrease in TM (7.38 vs. 2.67, 
Z =- 2.826, p=0, 005).  
The FEV1/FVC ratio increased by 4.27 in 
one group and 2.14 in the other group of patients 
(Z=- 2.288, p=0.022). This clearly shows that 
there was no significant difference in the values 
of the parameter FEV 1 / FVC, which reflects the 
lung function among subjects of groups 2, 3 and 
4. We can therefore draw a conclusion that obesity 
does not affect the decrease in spirometric 
parameters in patients with COPD. 
Table 2 shows the values of observed 
parameters related to obesity. By  comparing the 
height between the analyzed groups, there is a 
statistically significant difference (F=17,663, 
p<0,0001). Patents in groups 3 (1,75±0,10), 4 
(1,77±0,06) and 1b (1,78±0,03) had higher 
v a l u e s  o f  b o d y  h e i g h t  c o m p a r e d  t o  p a t i e n t s  i n  
group 1a (1,64±0,05), while the body height 
values in the groups 2 (1,68±0,06) and 3 were 
lower than in group 1b. Statistically significantly 
higher values of height were  reported in  group 
4 compared to group 2. 
Statistically significant differences in body 
weight were also noticed among the analyzed 
groups (F=35,392, p<0,0001). The highest body 
weight values were reported in patients in group 4 
(110,46±10,92), which was statistically significantly 
higher compared to group 1a (87.10±13.89),   
group 2 (79,56±16,46) and group 3 (90,46±12,33). 
The lowest body weight measurements were 
recorded in group 2 examinees, that was statisti-
cally lower than in the groups 1b (103,55±17,03), 
3 and 4. 
By applying the analysis of variance, 
statistically significant differences between the 
investigated has been observed by comparing the 
waist scope (F=36,996, p<0,0001). The largest 
waist scope was recorded in 4 group patients 
(116,74±10,92), which is statistically significantly 
higher compared to examinees in groups 1a   
(94,45±12,63), 2 (88,08±13,14) and 3 (96,16± 
9,53). The lowest waist scope was found in group 
2, and it was statistically lower than in subjects 
of groups 1b (109,10±20,86), 3 and 4. 
 
Discussion 
 
Observing the data obtained in a large 
number of studies dealing with defining the 
important parameters characteristic of people with 
COPD and obesity, as well as the inter-relationship 
and influence of these two diseases, it was 
concluded that the following methodological 
parameters have important role in examining, 
determining the relationships and understanding 
the interaction of these two diseases.  
The obesity-related parameters are: age 
when obesity begins, duration of obesity until the 
beginning of investigations, degree of obesity, 
presence of abdominal obesity; the COPD-related 
parameters are: FEV1, FEV1/FVC, 6-minute test, 
duration of cigarette smoking,  length of COPD until 
the beginning of investigations, presence of 
dyspnea, the number of exacerbations of COPD 
during one year, sputum volume ejected during one 
year. 
Numerous studies conducted so far have not 
shown significant differences in spirometric 
parameters between the degree of obesity, and 
subjects with normal body weight.   
  Obesity significantly influences the life 
quality of COPD patients, affects the frequency of 
dyspnea, reduces physical fatigue threshold, affects 
the occurrence of frequent exacerbations, but its 
direct influence on the values of spirometric 
parameters has not been proved yet. This fact has 
initiated the investigations into the relationship 
between obesity and spirometric parameters. 
Furthermore, it helped introducing significant 
methodological parameters important for the 
management of COPD  (6).  
Influence of weight reduction on dyspnea, 
tolerance exercises and quality of life in overweight 
and obese patients with COPD has not yet been 
significantly described in the literature. There are 
studies showing that weight loss leads to improved 
lung function and symptoms, regardless of the 
degree of obstructive changes in the respiratory 
system (7, 8). Acta Medica Medianae 2011, Vol.50(4)                                                Influence of obesity on spirometric parameters in patients... 
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Given results have shown that the length of 
obesity with tendency to increase in the reported 
period is a significant negative predictor for lung 
function of the observed performance (p>0.001), 
(the ratio of FEV1/FVC (p>0.001) and diffusion 
capacity (p>0.001) (9). 
By analyzing the spirometric parameters of 
FEV1 values, it has been observed that the obese 
examinees had better results which amounted to 
50.0%, i.e. 20.4% of predicted amount,  compared 
to normal patient whose FEV 1 was on average   
44.2%, i.e. 19, 4% of predicted amount (10) .  
 
Conclusions 
 
1.    Obesity has no significant effect on spiro-
metric parameters in patients with COPD. 
2.    Losing weight in favor of adipose tissue 
reducing has a significant effect on improving the 
spirometric parameters in patients with COPD.  
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UTICAJ GOJAZNOSTI  NA SPIROMETRIJSKE PARAMETRE KOD 
BOLESNIKA SA HRONIČNOM OPSTRUKTIVNOM BOLEŠĆU PLUĆA 
  
Miroljub Đorđević 
 
 
Еmisija štetnih aero čestica (teška industrija, termo i nuklearne elektrane, prevozna 
sredstva koja sagorevaju fosilna goriva, profesionalno eksponiranje u fabrikama i 
rudnicima, konzumacija cigareta…),  u mnogome remeti funkciju respiratornog sistema. 
Gojaznost je udružena sa hroničnom inflamacijom niskog stepena i povećanim brojem 
aktiviranih makrofaga u masnom tkivu. Masno tkivo daje obilje inflamatornih medijatora, 
što sugeriše moguću povezanost gojaznosti sa imunološkim desavanjima u HOBP-u. 
  Cilj rada bio je utvrditi da li gojaznost ima značajan uticaj na spirometrijske 
parametere kod bolesnika sa HOBP-om i da li smanjenje telesne težine na račun 
smanjenja adipoznog tkiva ima pozitivan efekat na poboljšanje spirometrijskih 
parametara kod bolesnika sa HOBP-om. 
Ispitivanjem je obuhvaćeno 190 ispitanika starosti od 35 do 65 godina oba pola,  
podeljenih u četri grupe. Prvu grupu činilo je 40 ispitanika različitog stepena gojaznosti 
bez verifikovane HOBP i to (1a) sa prisutnom gojaznošću od I (ITM 30-35) do III (ITM 
>40) i (1b) sa prisutnom pred-gojaznošću (ITM 25-30). Drugu grupu (2) činilo je 50 
ispitanika, koji imaju normalnu uhranjenost i verifikovanu HOBP različite dužine trajanja. 
Treća grupa (3) od 50 ispitanika imala je gojaznost I stepena (ITM od 30-35) i 
verifikovanu HOBP i četvrta grupa (4) od 50 ispitanika oba pola imala je gojaznost II 
stepena (ITM od 35-40) i verifikovanu HOBP.  
  Vremanski interval u kome su trijažirani bolesnici za dato istraživanje iznosio je 
tri godine i odnosi se na period od 2007. do 2010. godine. Ispitanici su praćeni 180 
dana, zajedno sa svim promenama vezanim za spirometrijske parametre i indeks telesne 
mase (ITM). 
 Poređenjem srednjih vrednosti i standardnih devijacija za FEV1/FVC odnos 
između: grupa 4 (66,71 ± 4,53), 2 (69,1 ± 5,98) i 3 (70,69 ± 5,81), nije uočena 
značajna statistička razlika. Upoređujući vrednosti spirometrijskih parametara između 
dve grupe bolesnika sa HOBP-om. Prve (1) u kojoj su bili ispitanici koji su uperiodu od 
180 dana imali gubitak telesne mase veći od 10% i druge (2) u kojoj su bili ispitanici bez 
značajnog gubitka u telesnoj masi. Ustanovljeno je da su ispitanici iz prve grupe imali 
statistički značajno povećanje vrednosti svih posmatranih spirometrijskih parametara u 
odnosu na drugu grupu: FVC: 4.33(1) 0.99(2); p<0,01. FEV1: 7.38(1) 2.67(2); p<0.01. 
FEV1/FVC: 4,27(1) 2,14(2); p<0,05.  
Gojaznost nema značajan efekat na spirometrijske parametre u bolesnika sa HOBP. 
Redukcija telesne težine i količine masnog tiva ima značajan efekat na popravljanje 
spirometrijskih pokazatelja sa HOBP. Acta Medica Medianae 2011;50(4):11-16.   
 
Ključne reči: gojaznost, odnos, hronična respiratorna bolest pluća (HOBP), 
spirometrijski parametri, indeks telesne mase (ITM) 
 
 